
Nixobect CL 500mg/200mg Injection
Marketer
Pharmus Biotech
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (200mg)
Overview Nixobect CL 500mg/200mg Injection
Cilapen-CL 500mg/200mg Injection is a penicillin-based antibiotic combating bacterial infections. It treats lung (pneumonia, for instance), ear, sinus, urinary tract, skin, and soft tissue infections. It's ineffective against viral illnesses like the common cold. Administration is exclusively by a healthcare provider; self-injection is prohibited. Dosage and frequency are determined by your doctor based on your condition. Always adhere to prescribed usage. Typical side effects include nausea, vomiting, diarrhea, and oral thrush. Injection site reactions (pain, swelling, redness) may also occur. Report persistent or worsening side effects to your physician. Patients with severe liver or kidney impairment should consult their doctor before commencing treatment. Inform your doctor of any antibiotic allergies or kidney/liver issues prior to use; dosage adjustments or alternative medications may be necessary. Generally considered safe during pregnancy and breastfeeding under medical supervision.
Primary Ingredients of Nixobect CL 500mg/200mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Nixobect CL 500mg/200mg Injection
Preventing bacterial infections related to surgical procedures
Major Benefits of Nixobect CL 500mg/200mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Nixobect CL 500mg/200mg Injection:
- Vomiting
- Nausea
- Diarrhea
- Thrush
How to use Nixobect CL 500mg/200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Nixobect CL 500mg/200mg Injection works:
Nixobect CL Injection, containing 500mg Amoxicillin and 200mg Clavulanic Acid, combines an antibiotic with a beta-lactamase inhibitor. Amoxicillin's antibacterial action disrupts bacterial cell wall synthesis, hindering bacterial survival. Clavulanic Acid counteracts bacterial resistance mechanisms, thus boosting Amoxicillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from co-ingesting alcohol and Nixobect CL 500mg/200mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Nixobect CL, 500mg/200mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal to no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Nixobect CL 500mg/200mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Administering Nixobect CL 500mg/200mg Injection may result in adverse reactions, potentially impairing driving ability. These reactions can include allergic responses, vertigo, or seizures, rendering operation of a vehicle unsafe.
KidneyCAUTION
The injectable combination Nixobect CL (500mg/200mg) requires careful administration in individuals with kidney impairment. Dosage modification of Nixobect CL Injection (500mg/200mg) may be necessary. Physician consultation is advised. Nixobect CL (500mg/200mg) Injection is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
The use of Nixobect CL 500mg/200mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Nixobect CL 500mg/200mg Injection might be necessary. Physician consultation is advised. Routine assessment of liver function is recommended during treatment.
What if you forget to take Nixobect CL 500mg/200mg Injection :
Should you forget a Nixobect CL 500mg/200mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nixobect CL 500mg/200mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
